{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:47:30Z","timestamp":1763635650724,"version":"3.45.0"},"reference-count":23,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Prostate cancer (PC) is largely a disease of elderly men, and de novo metastatic presentations are increasingly reported in this population. Yet older patients remain underrepresented in clinical trials, limiting the applicability of guideline-based treatments. Materials and Methods: We retrospectively analyzed 90 patients aged \u226575 years with de novo metastatic castration-sensitive PC (mCSPC) to describe clinical features, treatment patterns, and survival outcomes. Results: Median age was 81 years; high-volume disease and Gleason grade 9\u201310 tumors predominated. A substantial portion of patients received androgen deprivation therapy (ADT) alone or with bicalutamide despite recommendations for intensified therapy. Enzalutamide was associated with the longest median progression-free survival (PFS, 25.4 months) and overall survival (OS, 30.5 months), though between-group differences were not significant. Castration resistance occurred only in the high-volume group (22.4%). Absence of hypertension was associated with a lower risk of progression (HR 0.46, 95% CI 0.23\u20130.92, p = 0.028). Conclusions: Elderly patients with de novo mCSPC often have aggressive forms of the disease. Enzalutamide was associated with numerically longer survival compared to other treatments, although the difference was not statistically significant. Additionally, the absence of hypertension appeared to be linked with a lower risk of progression, suggesting that comorbid conditions such as hypertension may influence treatment outcomes in elderly patients.<\/jats:p>","DOI":"10.3390\/medicina61112068","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:44:53Z","timestamp":1763631893000},"page":"2068","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9030-022X","authenticated-orcid":false,"given":"Ugur","family":"Ozberk","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin Akturk","family":"Esen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-106X","authenticated-orcid":false,"given":"Alican","family":"Uguz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efnan","family":"Alg\u0131n","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-2646","authenticated-orcid":false,"given":"Oznur","family":"Bal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7575-9925","authenticated-orcid":false,"given":"Bulent","family":"Ak\u0131nc\u0131","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-3271","authenticated-orcid":false,"given":"Dogan","family":"Uncu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1055-9965.EPI-22-1038","article-title":"Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States","volume":"32","author":"Devasia","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e222246","DOI":"10.1001\/jamanetworkopen.2022.2246","article-title":"Trends in Incidence of Metastatic Prostate Cancer in the US","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-5347(05)64820-3","article-title":"Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"168","author":"Huggins","year":"2002","journal-title":"J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaoncol.2022.5511","article-title":"Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis","volume":"9","author":"Riaz","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1200\/JCO.2012.41.6727","article-title":"Under-representation of older adults in cancer registration trials: Known problem, little progress","volume":"30","author":"Scher","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/003655902320783827","article-title":"Calculated fast-growing benign prostatic hyperplasia\u2014A risk factor for developing clinical prostate cancer","volume":"36","author":"Hammarsten","year":"2002","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(02)01049-5","article-title":"Is there an association between hypertension and cancer mortality?","volume":"112","author":"Grossman","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000058061","article-title":"Prognostic factors for survival in invasive squamous cell vulvar carcinoma: A univariate analysis","volume":"51","author":"Kouvaris","year":"2001","journal-title":"Gynecol. Obs. Obstet. Investig."},{"key":"ref_12","first-page":"367","article-title":"Physiopathologic effects of nitric oxide and their relationship with oxidative stress","volume":"58","author":"Carrizo","year":"1998","journal-title":"Medicina"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_14","first-page":"1227","article-title":"Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells","volume":"20","author":"Yoshiji","year":"2002","journal-title":"Int. J. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11906-002-0007-4","article-title":"Carcinogenicity of antihypertensive therapy","volume":"4","author":"Grossman","year":"2002","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.31802","article-title":"Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study","volume":"144","author":"Santala","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/EDE.0000000000000174","article-title":"Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations","volume":"25","author":"Haggstrom","year":"2014","journal-title":"Epidemiology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/cncr.26392","article-title":"Prostate cancer in the elderly: Frequency of advanced disease at presentation and disease-specific mortality","volume":"118","author":"Scosyrev","year":"2012","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2013.01.007","article-title":"Management of prostate cancer in elderly men","volume":"23","author":"Bian","year":"2013","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0022-5347(06)00266-7","article-title":"Prevalence of prostate specific antigen testing for prostate cancer in elderly men","volume":"175","author":"Dyche","year":"2006","journal-title":"J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e390396","DOI":"10.1200\/EDBK_390396","article-title":"Management of Prostate Cancer in Older Adults","volume":"43","author":"Graham","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2068\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:44:21Z","timestamp":1763635461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61112068"],"URL":"https:\/\/doi.org\/10.3390\/medicina61112068","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}